Alzheimer's disease
Atherosclerosis
The proprietor of this website is processing the personal data as a trustee for Affiris GmbH, Viehmarktgasse 2 A, 1030 Vienna
Alzheimer's disease
Two Alzheimer vaccines developed by Affiris, AFFITOPE AD01 and AFFITOPE AD02, have successfully passed the preclinical development phase and are entering the stage of clinical testing.
I consider participation in the AFFITOPE AD01 study|
I consider participation in the AFFITOPE AD02 studyAtherosclerosis
In preparation